Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Financings In Brief

This article was originally published in The Gray Sheet

Executive Summary

Mentor: Santa Barbara, Calif. firm completes three-year syndicated credit agreement providing up to $200 mil. for pursuit of "licensing and acquisition opportunities" in markets where Mentor already competes, President & CEO Joshua Levine says. Bank of the West and Union Bank of California sponsored the agreement, which provides the option for a $50 mil. increase in the future. Separately, Mentor plans to launch its Hyalite non-animal stabilized hyaluronic acid, which it acquired through its 2003 purchase of A-life, in early 2006 (1"The Gray Sheet" May 30, 2005, p. 19). Hyalite will compete against Inamed's Hylaform avian-derived and Captique non-animal fillers, and Medicis' non-animal Restylane...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT022267

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel